Paradigm Biocapital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value per share (YMAB)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
YMAB
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:31:30 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 0% 0 0 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 0% 0 0 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 0% 0 0 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 0% 0 0 0 /s/ David K. Kim David K. Kim / Authorized Signatory